ALGONQUIN PWR & UTILITY - AQNCN 6.2 07/01/2079 (AQNB)

US0158578080

24.92  -0.07 (-0.28%)

Fundamental Rating

3

Taking everything into account, AQNB scores 3 out of 10 in our fundamental rating. AQNB was compared to 26 industry peers in the Multi-Utilities industry. AQNB has a medium profitability rating, but doesn't score so well on its financial health evaluation. AQNB is valued expensive and it does not seem to be growing.



4

1. Profitability

1.1 Basic Checks

In the past year AQNB was profitable.
AQNB had a positive operating cash flow in the past year.
Of the past 5 years AQNB 4 years were profitable.
Each year in the past 5 years AQNB had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 0.11%, AQNB is doing worse than 92.31% of the companies in the same industry.
AQNB's Return On Equity of 0.40% is on the low side compared to the rest of the industry. AQNB is outperformed by 96.15% of its industry peers.
AQNB has a Return On Invested Capital of 2.36%. This is amonst the worse of the industry: AQNB underperforms 96.15% of its industry peers.
AQNB had an Average Return On Invested Capital over the past 3 years of 2.30%. This is in line with the industry average of 3.63%.
The last Return On Invested Capital (2.36%) for AQNB is above the 3 year average (2.30%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.11%
ROE 0.4%
ROIC 2.36%
ROA(3y)0.13%
ROA(5y)2.2%
ROE(3y)0.18%
ROE(5y)5.78%
ROIC(3y)2.3%
ROIC(5y)2.45%

1.3 Margins

The Profit Margin of AQNB (0.75%) is worse than 92.31% of its industry peers.
AQNB's Profit Margin has declined in the last couple of years.
AQNB has a Operating Margin of 18.45%. This is comparable to the rest of the industry: AQNB outperforms 46.15% of its industry peers.
AQNB's Operating Margin has declined in the last couple of years.
AQNB's Gross Margin of 73.45% is fine compared to the rest of the industry. AQNB outperforms 76.92% of its industry peers.
AQNB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.45%
PM (TTM) 0.75%
GM 73.45%
OM growth 3Y-6.79%
OM growth 5Y-4.27%
PM growth 3Y-74.64%
PM growth 5Y-41.23%
GM growth 3Y-1.6%
GM growth 5Y0.32%

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AQNB is destroying value.
AQNB has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, AQNB has more shares outstanding
The debt/assets ratio for AQNB is higher compared to a year ago.

2.2 Solvency

AQNB has an Altman-Z score of 0.87. This is a bad value and indicates that AQNB is not financially healthy and even has some risk of bankruptcy.
With a decent Altman-Z score value of 0.87, AQNB is doing good in the industry, outperforming 65.38% of the companies in the same industry.
AQNB has a Debt/Equity ratio of 1.57. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of AQNB (1.57) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.57
Debt/FCF N/A
Altman-Z 0.87
ROIC/WACC0.35
WACC6.67%

2.3 Liquidity

AQNB has a Current Ratio of 0.63. This is a bad value and indicates that AQNB is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.63, AQNB is doing worse than 80.77% of the companies in the same industry.
A Quick Ratio of 0.53 indicates that AQNB may have some problems paying its short term obligations.
AQNB's Quick ratio of 0.53 is on the low side compared to the rest of the industry. AQNB is outperformed by 80.77% of its industry peers.
Industry RankSector Rank
Current Ratio 0.63
Quick Ratio 0.53

3

3. Growth

3.1 Past

The earnings per share for AQNB have decreased strongly by -25.71% in the last year.
Measured over the past years, AQNB shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.95% on average per year.
Looking at the last year, AQNB shows a decrease in Revenue. The Revenue has decreased by -2.43% in the last year.
AQNB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.35% yearly.
EPS 1Y (TTM)-25.71%
EPS 3Y-6.69%
EPS 5Y-4.95%
EPS growth Q2Q-27.27%
Revenue 1Y (TTM)-2.43%
Revenue growth 3Y17.17%
Revenue growth 5Y10.35%
Revenue growth Q2Q-9.71%

3.2 Future

Based on estimates for the next years, AQNB will show a small growth in Earnings Per Share. The EPS will grow by 6.64% on average per year.
The Revenue is expected to grow by 1.98% on average over the next years.
EPS Next Y1.65%
EPS Next 2Y2.41%
EPS Next 3Y6.96%
EPS Next 5Y6.64%
Revenue Next Year6.79%
Revenue Next 2Y3.29%
Revenue Next 3Y4.17%
Revenue Next 5Y1.98%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 47.92, AQNB can be considered very expensive at the moment.
Based on the Price/Earnings ratio, AQNB is valued expensively inside the industry as 92.31% of the companies are valued cheaper.
Compared to an average S&P500 Price/Earnings ratio of 28.11, AQNB is valued quite expensively.
AQNB is valuated quite expensively with a Price/Forward Earnings ratio of 47.15.
Based on the Price/Forward Earnings ratio, AQNB is valued more expensive than 96.15% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.39, AQNB is valued quite expensively.
Industry RankSector Rank
PE 47.92
Fwd PE 47.15

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AQNB is valued expensively inside the industry as 96.15% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 26.63

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)29.1
PEG (5Y)N/A
EPS Next 2Y2.41%
EPS Next 3Y6.96%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.43%, AQNB is a good candidate for dividend investing.
AQNB's Dividend Yield is rather good when compared to the industry average which is at 4.20. AQNB pays more dividend than 100.00% of the companies in the same industry.
AQNB's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 6.43%

5.2 History

The dividend of AQNB has a limited annual growth rate of 4.94%.
AQNB has been paying a dividend for over 5 years, so it has already some track record.
AQNB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)4.94%
Div Incr Years0
Div Non Decr Years3

5.3 Sustainability

1628.23% of the earnings are spent on dividend by AQNB. This is not a sustainable payout ratio.
The dividend of AQNB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP1628.23%
EPS Next 2Y2.41%
EPS Next 3Y6.96%

ALGONQUIN PWR & UTILITY - AQNCN 6.2 07/01/2079

NYSE:AQNB (5/7/2024, 7:04:00 PM)

24.92

-0.07 (-0.28%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap17.18B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 6.43%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 47.92
Fwd PE 47.15
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)29.1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.11%
ROE 0.4%
ROCE
ROIC
ROICexc
ROICexgc
OM 18.45%
PM (TTM) 0.75%
GM 73.45%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 1.57
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.63
Quick Ratio 0.53
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-25.71%
EPS 3Y-6.69%
EPS 5Y
EPS growth Q2Q
EPS Next Y1.65%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-2.43%
Revenue growth 3Y17.17%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y